The prevalence of pre-diabetes and diabetes in people with and without past history of COVID-19 in northeastern Nigeria

Author:

Stephen Roland1,Tyndal Jennifer2,Hsu Vivian3,Sun Jing3,Umaru Nura4,Olumoh Jamiu2,Adegboye Oyelola5,Owobi Olah U.6,Brown Todd T.7

Affiliation:

1. Modibbo Adama University Teaching Hospital

2. American University of Nigeria

3. Johns Hopkins Bloomberg School of Public Health

4. Federal Teaching Hospital

5. Charles Darwin University

6. International Child Health and Social Services Award project (USAID Funded)

7. Johns Hopkins University

Abstract

Abstract Background An increased risk of diabetes mellitus (DM) after COVID-19 has been reported in the United States, Europe, and Asia. The burden of COVID-related DM has not been described in Africa, where the overall risk of DM has been increasing rapidly. Our objective was to compare the prevalence of pre-DM and DM in Nigerian individuals with a history of COVID-19 to individuals without known COVID-19 infection. Methods We identified 256 individuals with a past medical history of COVID-19 with no history of pre-DM or DM and 256 individuals without a history of COVID-19 or pre-DM/DM. Participants were categorized as pre-DM (fasting capillary glucose 100–125 mg/dL) or DM (fasting capillary glucose ≥ 126 mg/dL). We used multivariate multinomial logistic regression to determine the odds of pre-DM and DM in those with and without a history of COVID-19 after adjustment for age, gender, the presence of hypertension, physical activity, central adiposity, and family history of DM. Results Compared to the control group, those with a history of COVID-19 had a similar median age (38 vs 40 years, p = 0.84), had a higher proportion of men (63% vs 49%), and had a lower prevalence of central adiposity (waist: hip ratio ≥ 0.90 for males and WHR ≥ 0.85 for females) (48% vs 56.3%, p = 0.06). Of the 256 with a history of COVID-19, 44 (17%) required inpatient care. The median (interquartile range) time interval between COVID-19 diagnosis and the glycaemic assessment was 19 (14, 24) months. Pre-DM prevalence was 27% in the post-COVID-19 group and 4% in the control group, whereas the prevalence of DM was 7% in the post-COVID-19 group and 2% in the control group. After multivariable adjustment, the odds of pre-DM were 8.12 (95% confidence interval (CI): 33.98, 16.58; p < 0.001) higher, and the odds of DM were 3.97 (95% CI: 1.16, 13.63) higher in those with a history of COVID-19 compared to controls. Conclusion Previous COVID-19 was found to be a risk factor for prevalent pre-diabetes and diabetes mellitus in Nigeria. More intensive screening for DM in those with a history of COVID-19 should be considered.

Publisher

Research Square Platform LLC

Reference34 articles.

1. White-Dzuro G, Gibson LE, Zazzeron L, White-Dzuro C, Sullivan Z, Diiorio DA, et al. Multisystem effects of COVID-19: a concise review for practitioners. Postgraduate Medicine. Volume 133. Bellwether Publishing, Ltd.; 2021. pp. 20–7.

2. Risk for newly diagnosed diabetes after COVID-19: a systematic review and meta-analysis;Zhang T;BMC Med,2022

3. New-onset diabetes in COVID-19 and clinical outcomes: A systematic review and meta-analysis;Shrestha DB;World J Virol,2021

4. Risk for newly diagnosed diabetes after COVID-19: a systematic review and meta-analysis;Zhang T;BMC Med,2022

5. Lim S, Bae JH, Kwon HS, Nauck MA. COVID-19 and diabetes mellitus: from pathophysiology to clinical management. Nature Reviews Endocrinology. Volume 17. Nature Research; 2021. pp. 11–30.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3